Omeros (OMER) Current Deferred Revenue (2010 - 2026)

Omeros' (OMER) quarterly Current Deferred Revenue came in at $2.8 million in Q1 2026, up 13.99% quarter-over-quarter from $2.5 million in Q4 2025.

Omeros (OMER) Current Deferred Revenue (2010 - 2026) Analysis & Trends

Omeros has disclosed Current Deferred Revenue across 9 years of filings, most recently posting $2.8 million for Q1 2026.

  • Current Deferred Revenue for Q1 2026 came in at $2.8 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $2.8 million (changed N/A YoY), and the FY2025 annual result was $2.5 million, up 1251.37% from the prior year.
  • Current Deferred Revenue came in at $2.8 million for Q1 2026 at Omeros, up from $2.5 million in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $2.8 million in Q1 2026 to a low of $183000.0 in Q4 2024.
  • The 3-year median for Current Deferred Revenue is $2.5 million (2025), against an average of $1.8 million.
  • Peak annual rise in Current Deferred Revenue reached 1251.37% in 2025, while the deepest fall reached 1251.37% in 2025.
  • Omeros' Current Deferred Revenue stood at $183000.0 in 2024, then jumped by 1251.37% to $2.5 million in 2025, then increased by 13.99% to $2.8 million in 2026.
  • The last three Current Deferred Revenue figures came in at $2.8 million (Q1 2026), $2.5 million (Q4 2025), and $183000.0 (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Omeros 737.87 Mn 602.55 Mn 9.31 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 2.82 Mn
Dec 31, 2025 2.47 Mn
Dec 31, 2024 183,000.00
Sep 30, 2017 381,000.00
Jun 30, 2017 288,000.00
Dec 31, 2016 102,000.00
Mar 31, 2013 1.83 Mn
Dec 31, 2012 970,000.00
Sep 30, 2012 2.41 Mn
Jun 30, 2012 3.74 Mn
Mar 31, 2012 5.00 Mn
Dec 31, 2011 2.00 Mn
Sep 30, 2011 6.28 Mn
Jun 30, 2011 6.79 Mn
Dec 31, 2010 8.01 Mn